Regulatory landscape
Selank's legal status is a genuine patchwork: a registered medicine in Russia; in the United States, no FDA-approved…
One molecule, a patchwork of legal realities
Selank's legal status is a genuine patchwork: a registered medicine in Russia; in the United States, no FDA-approved label and no DailyMed labelling record, plus a compounding history in which FDA placed it in a safety-risk category and later removed it; and for athletes, a substance the WADA Prohibited List does not name.
This unit maps that landscape jurisdiction by jurisdiction, explains the 503A saga, and connects the regulatory picture to the practical problem of product quality that follows from it.
Key terms
The jurisdiction map
Where you are determines what Selank legally is. It is a registered medicine in Russia; in the United States no FDA-approved label carries its name; and the WADA Prohibited List does not name it, which is not the same as clearing it. Tap each jurisdiction to see its specific stance. One caution about the map: it lists the jurisdictions this course could check directly, so "not shown" means "not examined here" rather than "confirmed absent."
The map captures Selank's core oddity: it is simultaneously a legitimate registered medicine and an unapproved research chemical, depending only on the border. That split is not a loophole to exploit; it is the reason a Western buyer cannot assume the quality, oversight, or legal protections that a Russian patient receives.
AdvancedWhy "registered in Russia" does not help US users
Russian registration applies to a specific manufactured product, one manufacturer's finished nasal drops with an instruction for use, not to the molecule everywhere. Anything obtained elsewhere is a different product from a different supply chain with no regulator standing behind it. So "it is an approved medicine in Russia" is true and provides no assurance whatsoever about a vial bought in the US, a distinction that is easy to blur.